CANC Holdings Information

CANC is an equity ETF with a total of 57 individual holdings. The top holdings are Revolution Medicines stock at 6.31%, Novartis AG at 4.76%, Eli Lilly and Company at 4.46%, AstraZeneca at 4.45%, and Roche Holding AG at 4.39%.

Total Holdings

Top 10 Percentage

43.25%

Asset Class

Equity

ETF Category

Health

Assets

146.82M

PE Ratio

19.80

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	RVMD	Revolution Medicines, Inc.	6.31%	96,261
2	SWX: NOVN	Novartis AG	4.76%	45,584
3	LLY	Eli Lilly and Company	4.46%	6,415
4	LON: AZN	AstraZeneca PLC	4.45%	34,490
5	RHHBY	Roche Holding AG	4.39%	112,834
6	BMY	Bristol-Myers Squibb Company	4.28%	105,637
7	MRK	Merck & Co., Inc.	3.95%	48,460
8	BBIO	BridgeBio Pharma, Inc.	3.84%	88,318
9	GMAB	Genmab A/S	3.50%	165,724
10	NUVL	Nuvalent, Inc.	3.31%	48,079
11	COGT	Cogent Biosciences, Inc.	3.21%	132,168
12	IMNM	Immunome, Inc.	2.90%	177,434
13	AMGN	Amgen Inc.	2.72%	10,867
14	ABBV	AbbVie Inc.	2.69%	17,999
15	JNJ	Johnson & Johnson	2.57%	15,877
16	CELC	Celcuity Inc.	2.45%	34,541
17	ACLX	Arcellx, Inc.	2.41%	52,859
18	EXEL	Exelixis, Inc.	2.25%	77,769
19	ONC	BeOne Medicines AG	2.07%	8,750
20	IDYA	IDEAYA Biosciences, Inc.	1.89%	87,138
21	SNDX	Syndax Pharmaceuticals, Inc.	1.71%	124,353
22	HALO	Halozyme Therapeutics, Inc.	1.56%	29,168
23	CGON	CG Oncology, Inc.	1.50%	44,805
24	GILD	Gilead Sciences, Inc.	1.42%	13,974
25	ZYME	Zymeworks Inc.	1.42%	94,443

Showing 25 of 57 holdings

Subscribe to see the full list

Activate Now

As of Feb 5, 2026